✦ LIBER ✦

A novel treatment strategy for type 2 diabetes: Targeting glucose variability and β-cell failure

✍ Scribed by Jia Deng; Bochu Wang; Yang Cao; Liancai Zhu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucose regulation of islet stress respo

✍ J. C. Jonas; M. Bensellam; J. Duprez; H. Elouil; Y. Guiot; S. M. A. Pascal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Targeting VEGF-B as a novel treatment fo

✍ Hagberg, Carolina E.; Mehlem, Annika; Falkevall, Annelie; Muhl, Lars; Fam, Barba 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 503 KB

Dapagliflozin: A Novel Sodium-Glucose Co

✍ Niren K. Shah; Wasim E. Deeb; Rushab Choksi; Benjamin J. Epstein 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Targeting β-cell cyclic 3′5′adenosine mo

✍ Brian Furman; Nigel Pyne; Peter Flatt; Finbarr O'Harte 📂 Article 📅 2004 🏛 Pharmaceutical Press 🌐 English ⚖ 250 KB

AS1907417, a novel GPR119 agonist, as an

✍ Shigeru Yoshida; Hirotsugu Tanaka; Hiroyuki Oshima; Takao Yamazaki; Yasuhiro Yon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 753 KB

5a-Carba-β-d-glucopyranose derivatives a

✍ Yoshihito Ohtake; Tsutomu Sato; Hiroharu Matsuoka; Masahiro Nishimoto; Naoki Tak 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 658 KB